Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Reanne Booker, MN, NP

Advertisement

Articles by Reanne Booker, MN, NP

Reanne Booker on Factors to Consider When Discussing Palliative Radiation

Reanne Booker on Factors to Consider When Discussing Palliative Radiation

ByReanne Booker, MN, NP
February 14th 2023

Reanne Booker, MN, NP, highlights factors that make a patient a good candidate for palliative radiation.

Advertisement

Latest Updated Articles

  • Reanne Booker on Factors to Consider When Discussing Palliative Radiation
    Reanne Booker on Factors to Consider When Discussing Palliative Radiation

    February 14th 2023



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses

2

Addressing Financial Toxicity: Team-Based Workflows in Oncology Care

3

Managing Daraxonrasib: Key Takeaways and Efficacy Insights for Oncology Nurses

4

FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer

5

SBRT Reduces Bowel Toxicity in Localized Intermediate-Risk Prostate Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us